OClawVPS.com
Kyulux Inc
Edit

Kyulux Inc

https://www.kyulux.com/
Last activity: 23.12.2025
Active
Categories: BusinessChemicalFutureManufacturingMaterialsMetalsOrganicTechnologyUniversity
Kyulux was established in Japan in 2015 to develop next generation materials for OLED displays and l
Likes
974
Followers
456
Followers
1.62K
Mentions
6
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $45.3M
Founded date: 2015

Investors 7

Funding Rounds 2

DateSeriesAmountInvestors
27.05.2019-$31.8M-
06.04.2016Series A$13.5M-

Mentions in press and media 6

DateTitleDescription
23.12.2025Business Beyond Boundaries: The future of display technology in 2026-
14.09.2017Samsung and LG invest $30 million in Germany’s Cynora to create more efficient OLED displaysSamsung, via its investment arm Samsung Ventures, and LG, through its LG Display division, have invested €25 million ($30 million) in German OLED company Cynora. With OLED emerging as the technology of choice for displays across mobile devi...
14.09.2017Samsung and LG invest $30 million in Germany’s Cynora to create more efficient OLED displaysDid you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more. Samsung, via its investment arm Samsung Ventures, and LG, through its LG Display division, have invested €25 million ($30 million) in G...
08.04.2016Samsung Venture leads $13.5m round for Japan’s KyuluxPremium South Korea’s Samsung Venture Investment Corporation has taken the lead in a 1.5 billion yen ($13.5 million) series A round for Kyulux Inc, Japan’s Kyushu University’s startup that commercialises the next generation of OLED display ...
06.04.2016Kyulux Raises $13.5M in Series A VC FundingKyulux, Inc., a Fukuoka, Japan-based advanced materials startup that is commercializing the next generation of OLED display and lighting technology known as TADF (Thermally Activated Delayed Fluorescence), raised $13.5m (¥1.5 Billion Japane...
06.04.2016Daily funding roundup - April 6, 2016Bright Health secured $80M Series A; FinanzCheck closed Series C funding; CrossChx recieved $15M Qool Therapeutics, Inc., a Menlo Park, CA-based developer of non-invasive therapeutic hypothermia device for targeted temperature management an...

Reviews 0

Sign up to leave a review

Sign up Log In